Alpha 1-antitrypsin deficiency in a child with X-linked lymphoproliferative disease

Area of Science:

• Pediatric Hepatology
• Immunogenetics
• Rare Genetic Disorders

Background:

• X-linked lymphoproliferative disease (XLP) is a rare primary immunodeficiency often triggered by Epstein-Barr virus (EBV) infection.
• Persistent hepatic dysfunction post-EBV infection in XLP patients typically does not lead to cirrhosis.
• Alpha-1-antitrypsin deficiency (AATD) is a hereditary disorder that can cause liver and lung disease.

Observation:

• An 18-month-old infant with XLP presented with persistent liver dysfunction following EBV infection.
• Initial liver biopsy showed cirrhosis, an atypical finding for EBV infection in immunodeficient individuals.
• Subsequent testing revealed a homozygous Z phenotype, indicating alpha-1-antitrypsin deficiency.

Findings:

• The infant was diagnosed with a unique concurrence of X-linked lymphoproliferative disease and alpha-1-antitrypsin deficiency.
• Cirrhosis in this case was attributed to the co-existing hereditary conditions rather than EBV infection alone.
• This case underscores the importance of comprehensive genetic evaluation in complex pediatric liver disease.

Implications:

• Highlights the diagnostic challenge of co-existing rare genetic disorders.
• Emphasizes the need for considering multiple hereditary conditions in unexplained pediatric liver disease.
• Suggests potential for novel insights into the pathogenesis of liver disease in combined immunogenetic disorders.